Investment Strategy
Fidelity International Value Fund draws on Fidelity's 25 years of value-investing experience to uncover the best opportunities in the international market.
Fidelity International Value Fund
Performance
Annual compound performance – as at 31-Dec-2011
| Fund | Morningstar Quartile* |
Benchmark | |
| 1 month | -4.00% | 4 | -0.80% |
| 3 month | -1.15% | 4 | 0.97% |
| 6 month | -17.95% | 4 | -11.70% |
| 1 year | -18.25% | 4 | -9.97% |
| 2 year | -8.68% | 4 | -4.11% |
| 3 year | -1.70% | 4 | 0.96% |
| 5 year | -9.91% | 4 | -7.23% |
| 7 year | — | — | — |
| 10 year | — | — | — |
| YTD | -18.25% | 4 | -9.97% |
| Since Inception | -7.05% | — | -4.21% |
Calendar year performance – as at 31-Dec-2011
Growth of $10,000 since inception – as at 31-Jan-2012
Fund risk measures – as at 31-Dec-2011
| Fund | Benchmark | |
| Annual Standard Deviation | 17.10 | 14.89 |
| Beta | 1.12 | — |
| R² | 0.94 | — |
Risk measures are based on 3-year net returns (series B). (All returns are calculated in Canadian currency.)
Volatility meter
The volatility meter uses methodology recommended by the Fund Risk Classification Task Force of the Investment Funds Institute of Canada. The Task Force prescribes risk assessment based on historical volatility risk as measured by the standard deviation of fund performance. The Task Force also acknowledges that other types of measurable and nonmeasurable risk may exist. The Task Force reminds investors that historical performance may not be indicative of future returns and a fund’s historical volatility may not be indicative of future volatility.
View other Fidelity funds in this category:
Fund facts
NAVPU – Series B
$6.84 – as at 06-Feb-2012
Fund inception date
08-May-2006
Fund benchmark
MSCI EAFE Index
Fund aggregate assets (all series)
$8.1 million
as at 31-Jan-2012
Management expense ratio - Series B
2.36% – as at 30-Sep-2011
Quarterly Top Ten Holdings
| Royal Dutch Shell | |
| Roche Holding | |
| Sanofi | |
| Vodafone Group | |
| BHP Billiton | |
| BP | |
| Total | |
| Rio Tinto (Reg.) | |
| GlaxoSmithKline | |
| Nestlé (Reg.) | |
| Total number of holdings | 129 |
| Top 10 holdings aggregate | 20.6% |
Allocation to funds